Get the Stockscreener App
4.225
3.05%
0.125
After Hours:
4.30
0.075
+1.78%
Sophia Genetics Sa stock is traded at $4.225, with a volume of 136.61K.
It is up +3.05% in the last 24 hours and down -15.50% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$4.10
Open:
$4.12
24h Volume:
136.61K
Relative Volume:
0.78
Market Cap:
$286.65M
Revenue:
$64.49M
Net Income/Loss:
$-71.40M
P/E Ratio:
-3.8761
EPS:
-1.09
Net Cash Flow:
$-52.00M
1W Performance:
-8.15%
1M Performance:
-15.50%
6M Performance:
+23.90%
1Y Performance:
+36.29%
1-Day Range:
$4.005
$4.41
1-Week Range:
$4.005
$4.88
52-Week Range:
$2.58
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
4.225 | 278.17M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey
BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka
SOPHiA GENETICS (NASDAQ: SOPH) registers 75,000 warrant shares for resale - Stock Titan
BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com
Fulgent Genetics (FLGT) Earnings Transcript - AOL.com
SOPHiA GENETICS Q4 Earnings Call Highlights - MarketBeat
SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary - Yahoo Finance
SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript - The Globe and Mail
SOPHiA GENETICS SA reports results for the quarter ended December 31Earnings Summary - TradingView
SOPHiA GENETICS SA 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-03-03 - Seeking Alpha
SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat
Sophia Genetics reports fourth quarter and full year 2025 results - marketscreener.com
SOPHiA GENETICS (SOPH) 2025 20-F flags losses, platform and regulatory risks - Stock Titan
[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC FilingForm 6-K - Stock Titan
Sophia Genetics Q4 Earnings Summary & Key TakeawaysSophia Genetics (NASDAQ:SOPH) - Benzinga
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results - PR Newswire
A Look at Sophia Genetics's Upcoming Earnings Report - Benzinga
SOPHiA GENETICS (SOPH) to Release Earnings on Tuesday - Defense World
SOPH Should I Buy - Intellectia AI
SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Expands By 194.3% - MarketBeat
Why The SOPHiA GENETICS (SOPH) Narrative Is Shifting On Richer Valuation And Growth Expectations - Yahoo Finance UK
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference - Finviz
SOPHiA GENETICS (SOPH) Projected to Announce Earnings on Tuesday - MarketBeat
SOPH (NASDAQ) Rule 144 notice lists 684 restricted stock units and 10b5-1 sales - Stock Titan
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - ChartMill
Can SOPHiA GENETICS SA continue delivering strong returns2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Aug Patterns: Will SOPHiA GENETICS SA stock go up in YEARQuarterly Performance Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Moderna Just Crushed Estimates While Everyone Was Looking the Other Way - AOL.com
Can SOPHiA GENETICS SA (90B) stock deliver double digit returnsJobs Report & Free Safe Capital Growth Stock Tips - mfd.ru
Is SOPHiA GENETICS SA a potential multi baggerJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - mfd.ru
Day Trade: Can SOPHiA GENETICS SA sustain its profitabilityJuly 2025 Action & Long-Term Investment Growth Plans - baoquankhu1.vn
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems - Finviz
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer - Quantisnow
Aug Wrap: Can SOPHiA GENETICS SA sustain its profitability2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Painful week for individual investors invested in SOPHiA GENETICS SA (NASDAQ:SOPH) after 11% drop, institutions also suffered losses - simplywall.st
VIX Spike: Is SOPHiA GENETICS SA benefiting from interest rate changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 68.3% - MarketBeat
Should You Buy Guardant Health Before Feb. 19? - AOL.com
SOPHiA GENETICS Expands Perceptive Credit Facility With New $25 Million Term Loan Capacity and Additional Warrants - The Globe and Mail
Sophia Genetics amends credit agreement to add $25 million in loan commitments By Investing.com - Investing.com Nigeria
Sophia Genetics amends credit agreement to add $25 million in loan commitments - Investing.com Nigeria
1,409,160 Shares in SOPHiA GENETICS SA $SOPH Bought by Alta Wealth Advisors LLC - Defense World
Market Trends: Is SOPHiA GENETICS SA a potential multi baggerWeekly Investment Summary & Capital Protection Trading Alerts - baoquankhu1.vn
SOPHiA GENETICS (NASDAQ:SOPH) Trading Down 0.7%Here's What Happened - MarketBeat
SOPH: Guggenheim Raises Price Target While Maintaining Buy Ratin - GuruFocus
Growth Recap: Is SOPHiA GENETICS SA a momentum stockJuly 2025 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Pharma News: Is SOPHiA GENETICS SA benefiting from interest rate changesSwing Trade & Growth Focused Stock Pick Reports - baoquankhu1.vn
Market Catalysts: Is SOPHiA GENETICS SA exposed to political riskQuarterly Performance Summary & AI Powered Market Entry Strategies - baoquankhu1.vn
Setup Watch: How does BTC Digital Ltd perform in inflationary periodsPortfolio Growth Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):